Tummy tuck pain relief: nerve block may cut opioid use
NCT ID NCT01604694
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether an ultrasound-guided nerve block (TAP block) using the anesthetic levobupivacaine could reduce pain and the need for opioid painkillers after abdominoplasty (tummy tuck). Fifty-two adults undergoing the surgery were randomly assigned to receive either the active nerve block or a placebo (saline) injection. The main goal was to measure opioid use in the first 24 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- levobupivacaine (a local anesthetic) given as a TAP block injection
- What this could lead to
- If effective, this could provide a standard way to reduce pain and opioid use after tummy tuck surgery.
- What could go wrong
- This is a small, single-center trial with only 52 participants, so results may not apply broadly. The benefit over placebo may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
52 people
The number who actually took part.
- Start date
-
Jun 2012
- Finished
-
Oct 2013
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ASA1 or 2 patients * Undergoing abdominoplasty surgery in Centre François Xavier Michelet at Bordeaux University hospital * Age \>18 years old * Patient agreement by signing an informed consent Exclusion Criteria: * Psychiatric or neurological disease * Contraindication to regional anesthesia (haemostatic disorders, infection near to insertion point) * Double surgery * Long term opioid therapy * Pregnancy or breast-feeding * Allergy to any drug used in anesthesic or surgical procedure
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Abdominoplasty are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Bordeaux, Centre François-Xavier Michelet
Bordeaux, 33076, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can drain placement ease recovery after tummy tuck surgery?
- Which nerve block offers better pain control after tummy tuck?
- New study aims to make pain relief safer after abdominal surgery
- New pain drug shows promise in small tummy tuck study
- New nerve block combo aims to cut opioid use after colon surgery
- New study aims to find best pain block for kids after tummy surgery